YM BioSciences Reports CYT387 Phase I/II Results Selected by ASH Program Committee

News   Oct 12, 2012

 
YM BioSciences Reports CYT387 Phase I/II Results Selected by ASH Program Committee
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE